Suzhou Ark Biopharmaceutical patent describes compounds for RSV infection
July 31, 2023
Suzhou Ark Biopharmaceutical Co. Ltd. researchers have prepared and tested heteroaromatic bicyclic compounds reported to be useful for the treatment of respiratory syncytial virus (RSV) infection.